Literature DB >> 15529384

Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage.

Takumi Kakinuma1, Tadashi Yasuda, Takefumi Nakagawa, Teruko Hiramitsu, Miki Akiyoshi, Masao Akagi, Tatsuya Sawamura, Takashi Nakamura.   

Abstract

OBJECTIVE: To investigate for the presence of oxidized low-density lipoprotein (ox-LDL) and lectin-like oxidized LDL receptor 1 (LOX-1) in cartilage specimens from rheumatoid arthritis (RA) joints and to determine whether the interaction of ox-LDL with LOX-1 can induce matrix metalloproteinase 3 (MMP-3) in articular cartilage explant culture.
METHODS: Human articular cartilage specimens obtained from patients with RA, osteoarthritis (OA), and femoral neck fractures were examined for LOX-1 and ox-LDL by confocal fluorescence microscopy. The association between ox-LDL and LOX-1 was evaluated by immunofluorescence analysis. Articular cartilage specimens from patients with femoral neck fractures were incubated with ox-LDL, with or without preincubation with neutralizing anti-LOX-1 antibody. MMP-3 synthesis by chondrocytes in explant cartilage was evaluated by immunofluorescence, and protein secretion into conditioned medium was monitored by immunoblotting and enzyme-linked immunosorbent assay.
RESULTS: The majority of the RA chondrocytes stained positively with both anti-LOX-1 and anti-ox-LDL antibodies; however, no positive cells were found in OA and normal cartilage specimens. Anti-LOX-1 antibody suppressed the binding of DiI-labeled ox-LDL to chondrocytes in explant culture, suggesting that the interaction was mediated by LOX-1. In contrast to native LDL, ox-LDL induced MMP-3 synthesis by articular chondrocytes in association with the induction of LOX-1, which resulted in enhanced secretion of MMP-3 into the culture medium. Anti-LOX-1 antibody reversed ox-LDL-stimulated MMP-3 synthesis to control levels.
CONCLUSION: Ox-LDL, principally mediated by LOX-1, enhanced MMP-3 production in articular chondrocytes. Increased accumulation of ox-LDL with elevated expression of LOX-1 in RA cartilage indicates a specific role of the receptor-ligand interaction in cartilage pathology in RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15529384     DOI: 10.1002/art.20581

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; David Meriwether; Yuen Yin Lee; Ani Shahbazian; Srinivasa T Reddy
Journal:  Clin Rheumatol       Date:  2017-11-11       Impact factor: 2.980

2.  The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.

Authors:  M M Harnett; A J Melendez; W Harnett
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

3.  Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin.

Authors:  Y Luan; L Kong; D R Howell; K Ilalov; M Fajardo; X-H Bai; P E Di Cesare; M B Goldring; S B Abramson; C-J Liu
Journal:  Osteoarthritis Cartilage       Date:  2008-05-15       Impact factor: 6.576

4.  Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review.

Authors:  Inge C M van Eekeren; Stefan Clockaerts; Yvonne M Bastiaansen-Jenniskens; Eric Lubberts; Jan A N Verhaar; Gerjo J V M van Osch; Sita M Bierma-Zeinstra
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-02       Impact factor: 5.346

5.  SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis.

Authors:  Sokrates Stein; Christine Lohmann; Nicola Schäfer; Janin Hofmann; Lucia Rohrer; Christian Besler; Karin M Rothgiesser; Burkhard Becher; Michael O Hottiger; Jan Borén; Michael W McBurney; Ulf Landmesser; Thomas F Lüscher; Christian M Matter
Journal:  Eur Heart J       Date:  2010-04-23       Impact factor: 29.983

6.  Possible involvement of the oxLDL/LOX-1 system in the pathogenesis and progression of human intervertebral disc degeneration or herniation.

Authors:  Xinhua Li; Xuejun Wang; Zhouyang Hu; Zhaoxiong Chen; Haoxi Li; Xiaoming Liu; Zhi Yao Yong; Shanjing Wang; Zhanying Wei; Yingchao Han; Jun Tan; Cong Li; Xiao Bo He; Guixin Sun; Desheng Wu; Lijun Li
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

7.  Lectin-like, oxidized low-density lipoprotein receptor-1-deficient mice show resistance to age-related knee osteoarthritis.

Authors:  Kazuhiko Hashimoto; Yutaka Oda; Fumihisa Nakamura; Ryosuke Kakinoki; Masao Akagi
Journal:  Eur J Histochem       Date:  2017-02-14       Impact factor: 3.188

8.  LOX-1 deficient mice show resistance to zymosan-induced arthritis.

Authors:  Kazuhiko Hashimoto; Yutaka Oda; Koichi Nakagawa; Terumasa Ikeda; Kazuhiro Ohtani; Masao Akagi
Journal:  Eur J Histochem       Date:  2018-01-22       Impact factor: 3.188

Review 9.  Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics.

Authors:  Jonathan De Siqueira; Izma Abdul Zani; David A Russell; Stephen B Wheatcroft; Sreenivasan Ponnambalam; Shervanthi Homer-Vanniasinkam
Journal:  J Cardiovasc Transl Res       Date:  2015-09-18       Impact factor: 4.132

Review 10.  Lipid transport and metabolism in healthy and osteoarthritic cartilage.

Authors:  Amanda Villalvilla; Rodolfo Gómez; Raquel Largo; Gabriel Herrero-Beaumont
Journal:  Int J Mol Sci       Date:  2013-10-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.